|
[1] de REZENDE MM, D’ ALMEIDA V. Central and systemic responses to methionine-induced hyperhomocysteinemia in mice[J]. PLoS One, 2014, 9(8):e105704.
|
|
[2] LOW HQ, CHEN CP, KASIMAN K, et al. A comprehensive association analysis of homocysteine metabolic pathway genes in Singaporean Chinese with ischemic stroke[J]. PLoS One,2011, 6(9):e24757.
|
|
[3] BOSY-WESTPHAL A, PETERSEN S, HINRICHSEN H, et al.Increased plasma homocysteine in liver cirrhosis[J]. Hepatol Res, 2001, 20(1):28-38.
|
|
[4] MEDICI V, PEERSON JM, STABLER SP, et al. Impaired homoc-ysteine transsulfuration is an indicator of alcoholic liver disease[J]. J Hepatol, 2010, 53(3):551-557.
|
|
[5] ZEMLIANITSYNA O, POLOZOVA L, KARACHENTSEV I, et al.Features of excretion of melatonin in urine in patients with type2 diabetes mellitus and non-alcoholic fatty liver disease with anifestations of fibrosis and its relationship with certain metabolic and immunological indicators[J]. Georgian Med News,2018, 274:103-107.
|
|
[6] HU Y, LIU J, DONG X, et al. Clinical study of serum homocysteine and non-alcoholic fatty liver disease in euglycemic patients[J]. Med Sci Monit, 2016, 22:4146-4151.
|
|
[7] SHEN XW, SUN GH, SUN GZ, et al. Assessment of homocysteine concentration in chronic hepatic injury[J]. Chin J Hepatol, 2003, 11(4):242.(in Chinese）沈雄文，孙国红，孙关忠，等．肝损伤时血清同型半胱氨酸的浓度变化[J]．中华肝脏病杂志，2003, 11(4):242.
|
|
[8] McCULLY KS. vascular pathology of homocysteinemia:Implications for the pathogenesis of arteriosclerosis[J]. Am J Pathol, 1969, 56(1):111-128.
|
|
[9] STAMLER JS, OSBORNE JA, JARAKI O, et al. Adverse vascular effects of homocysteine are modulated by endotheliumderived relaxing factor and related oxides of nitrogen[J]. J Clin Invest, 1993, 91(1):308-318.
|
|
[10] STAMLER JS, JIA L, EU JP, et al. Blood flow regulation by Snitrosohemoglobin in the physiological oxygen gradient[J].Science, 1997, 276(5321):2034-2037.
|
|
[11] van der GRAAFF D, KWANTEN WJ, FRANCQUE SM. The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitis[J]. Med Hypotheses, 2019,122:188-197.
|
|
[12] TUNG HC, HSU SJ, TSAI MH, et al. Homocysteine deteriorates intrahepatic derangement and portal-systemic col aterals in cirrhotic rats[J]. Clin Sci(Lond), 2017, 131(1):69-86.
|
|
[13] KORKMAZ S, YILMAZ A, YILDIZ G, et al. Relationship between homocysteine and non-dipper pattern in patients with type 2 diabetes mellitus[J]. Arq Bras Endocrinol Metabol,2012, 56(5):285-290.
|
|
[14] ZHAO J, QI YF, YU YR. Research advances in the role of oxidative stress in the development and progression of liver fibrosis[J]. J Clin Hepatol, 2019, 35(9):2067-2071.(in Chinese）赵杰，齐永芬，鱼艳荣．氧化应激在肝纤维化发生发展中的作用[J]．临床肝胆病杂志，2019, 35(9):2067-2071.
|
|
[15] KUMAR M, SANDHIR R. Neuroprotective effect of hydrogen sulfide in hyperhomocysteinemia is mediated through antioxidant action involving Nrf2[J]. Neuromolecular Med, 2018, 20(4):475-490.
|
|
[16] GUPTA M, SHARMA P, GARG G, et al. Plasma homocysteine:An independent or an interactive risk factor for coronary artery disease[J]. Clin Chim Acta, 2005, 352(1-2):121-125.
|
|
[17] WILSON KM, LENTZ SR. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models[J]. SeminVascMed, 2005, 5(2):163-171.
|
|
[18] GUTHIKONDA S, HAYNES WG. Homocysteine:Role and implications in atherosclerosis[J]. Curr Atheroscler Rep, 2006,8(2):100-106.
|
|
[19] LOSCALZO J. The oxidant stress of hyperhomocyst(e)inemia[J]. J Clin Invest, 1996, 98(1):5-7.
|
|
[20] MOHAMMADIAN Z, EIDI A, MORTAZAVI P, et al. Effects of folic acid on dyslipidemia and serum homocysteine in a rat model of cholestasis and hepatic fibrosis[J]. Pol J Pathol,2015, 66(1):49-56.
|
|
[21] EL-MISSIRY MA, OTHMAN AI, EL-SAWY MR, et al. Neuroprotective effect of epigallocatechin-3-gallate(EGCG)on radiation-induced damage and apoptosis in the rat hippocampus[J]. Int J Radiat Biol, 2018, 94(9):798-808.
|
|
[22] FORD TC, DOWNEY LA, SIMPSON T, et al. The effect of a high-dose vitamin B multivitamin supplement on the relationship between brain metabolism and blood biomarkers of oxidative stress:A randomized control trial[J]. Nutrients, 2018, 10(12):e1860.
|
|
[23] STANGER O, WEGER M. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium[J]. Clin Chem Lab Med, 2003, 41(11):1444-1454.
|
|
[24] LI Y, JIANG C, XU G, et al. Homocysteine upregulates resistin production from adipocytes in vivo and in vitro[J]. Diabetes, 2008, 57(4):817-827.
|
|
[25] LI J, XUE YM, PAN YH, et al. The role of Hepatic insulin resistance in the pathogenesis of spontaneously diabetic OLETF rats[J]. China Med Herald, 2018, 15(14):12-16.(in Chinese）李佳，薛耀明，潘永华，等．肝脏胰岛素抵抗在自发性糖尿病OLETF大鼠发病中的作用[J]．中国医药导报，2018, 15(14):12-16.
|
|
[26] GUO YY, CHUN H, LUO QQ, et al. Dynamic fluctuation of blood glucose and its effects on prognosis in patients with nonalcoholic fatty liver disease complicated with type 2 diabetes mellitus[J]. J Clin Exp Med, 2019, 18(11):1173-1175.(in Chinese）郭郁郁，春华，罗清琼，等．非酒精性脂肪性肝病合并2型糖尿病患者血糖动态波动水平及其对预后的影响[J]．临床和实验医学杂志，2019, 18(11):1173-1175.
|
|
[27] FANG S,CAI YY, LI P, et al. Exendin-4 alleviates oxidative stress and liver fibrosis by activating Nrf2/HO-1 in streptozotocin-induced diabetic mice[J]. J South Med Univ, 2019,39(4):464-470.(in Chinese）方舒，蔡迎迎，李萍，等．Exendin-4通过激活Nrf2/HO-1通路减轻糖尿病小鼠的肝脏氧化应激及纤维化[J]．南方医科大学学报，2019, 39(4):464-470.
|
|
[28] SPADARO L, PRIVITERA G, FEDE G, et al. Diabetes increases renovascular impedance in patients with liver cirrhosis[J].Intern Emerg Med, 2015, 10(6):703-709.
|
|
[29] MUDALIAR S, HENRY RR, CIARALDI TP, et al. Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes[J]. Diabetes Obes Metab, 2016, 18(Suppl2):17-24.
|
|
[30] LI SJ, LIU H, LIU JM, et al. Effects of fluctuant high blood glucose on hepatic function and ultrastructure in diabetic rats[J]. J Hepatopancreatobiliary Surg, 2011, 23(1):7-10.(in Chinese）李素娟，刘浩，李剑敏，等．糖尿病大鼠血糖波动对肝脏功能及超微结构的影响[J]．肝胆胰外科杂志，2011, 23(1):7-10.
|
|
[31] PANG Y, KARTSONAKI C, TURNBULL I, et al. Diabetes,plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer:A prospective study of 0. 5 million people[J].Hepatology, 2018, 68(4):1308-1318.
|
|
[32] TUNG HC, HSU SJ, TSAI MH, et al. Homocysteine deteriorates intrahepatic derangement and portal-systemic col aterals in cirrhotic rats[J]. Clin Sci(Lond), 2017, 131(1):69-86.
|
|
[33] LI SX, LI LH, DANG XW. Research advances in the role of coagulation factors in liver fibrosis[J]. J Clin Hepatol, 2018, 34(7):1547-1550.(in chinese）李素新，李璐豪，党晓卫．凝血因素在肝纤维化发生发展中的作用[J]．临床肝胆病杂志，2018, 34(7):1547-1550.
|
|
[34] MEDICI V, PEERSON JM, STABLER SP, et al. Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease[J]. J Hepatol, 2010, 53(3):551-557.
|
DownLoad: